BioMarin Pharmaceutical
BMRN
#1409
Rank
NZ$21.42 B
Marketcap
$112.42
Share price
0.19%
Change (1 day)
-21.20%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): $1.27

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.31. In 2022 the company made an earnings per share (EPS) of $1.29 an increase over its 2021 EPS that were of -$0.59.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.27-1.17%
2022$1.29-319.62%
2021-$0.59-107.38%
2020$7.94-3485.71%
2019-$0.23-67.44%
2018-$0.72-34.85%
2017-$1.11-83.21%
2016-$6.59263.89%
2015-$1.8118.68%
2014-$1.53-28.91%
2013-$2.1534.74%
2012-$1.5993.88%
2011-$0.82-124.5%
2010$3.35
2009N/A-100%
2008$0.54-300%
2007-$0.27-54.29%
2006-$0.59-67.89%
2005-$1.83-62.54%
2004-$4.88136.59%
2003-$2.06-15.17%
2002-$2.43-11.59%
2001-$2.7556.19%
2000-$1.7610.53%
1999-$1.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.16-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.41-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.73-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.33 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.07-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.84 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA